Rigel Pharmaceuticals Inc (RIGL)
R&D Expense Growth
42.41%
Fiscal year · Period ending:
RIGL R&D Expense Growth
Latest reported42.41%period ending
Latest reported42.41%period ending
RIGL FY R&D Growth (YoY) (0.00% → 42.41%)
Latest values, visible window
High-resolution chart · PNG
RIGL r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 42.408% | |
| -4.657% | |
| -59.3144% | |
| -7.6107% | |
| 8.5456% | |
| 13.6447% | |
| 12.754% | |
| 1.3702% | |
| -27.0734% | |
| 0.9885% | |
| -7.1954% | |
| -10.1317% | |
| -4.3794% | |
| 13.5948% | |
| 7.6997% | |
| -29.0392% | |
| -17.2581% | |
| 55.861% | |
| 23.515% | |
| 9.4738% | |
| 7.244% | |
| 11.8995% | |
| 0.03% | |
| 34.1565% | |
| 0.8709% | |
| 87.202% | |
| 0% |